Page last updated: 2024-11-04

sobuzoxane and Diffuse Large B-Cell Lymphoma

sobuzoxane has been researched along with Diffuse Large B-Cell Lymphoma in 3 studies

sobuzoxane: used in treatment of leukemia L1210

Research Excerpts

ExcerptRelevanceReference

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsunoda, S1
Kobayashi, H1
Inoue, K1
Izumi, T1
Akutsu, M1
Katano, S1
Ueda, T1
Shirai, T1
Masuda, Y1
Ohmine, K1
Nagashima, T1
Ueda, M1
Takagi, S1
Muroi, K1
Ozawa, K1
Kano, Y1
Okamoto, T2
Nishimura, Y1
Yamada, S2
Itoh, T1
Mori, A2
Saheki, K1
Okada, M2
Takatsuka, H2
Wada, H1
Tamura, A1
Fujimori, Y1
Kakishita, E2
Wakae, T1

Other Studies

3 other studies available for sobuzoxane and Diffuse Large B-Cell Lymphoma

ArticleYear
[MTX-HOPE (methotrexate, hydrocortisone, vincristine, sobuzoxane, and etoposide) as a low-dose salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relati

2007
Long-term administration of oral low-dose topoisomerase II inhibitors, MST-16 and VP-16, for refractory or relapsed non-Hodgkin's lymphoma.
    Acta haematologica, 2000, Volume: 104, Issue:2-3

    Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sch

2000
Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16.
    International journal of hematology, 2002, Volume: 75, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytarabin

2002